• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微粒体介导的体外代谢:用于制备用于转化多巴胺转运蛋白成像的 PET 放射性配体代谢物 [F]FE-PE2I-OH 的便捷方法。

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [F]FE-PE2I-OH for Translational Dopamine Transporter Imaging.

机构信息

Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County Council, SE-171 76 Stockholm, Sweden.

PET Science Centre, Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Karolinska Institutet, S-171 76 Stockholm, Sweden.

出版信息

ACS Chem Neurosci. 2023 Oct 18;14(20):3732-3736. doi: 10.1021/acschemneuro.3c00458. Epub 2023 Sep 27.

DOI:10.1021/acschemneuro.3c00458
PMID:37753876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10587862/
Abstract

Undesired radiometabolites can be detrimental to the development of positron emission tomography (PET) radioligands. Methods for quantifying radioligand metabolites in brain tissue include ex vivo studies in small animals or labeling and imaging of the radiometabolite(s) of interest. The latter is a time- and resource-demanding process, which often includes multistep organic synthesis. We hypothesized that this process could be replaced by making use of liver microsomes, an in vitro system that mimics metabolism. In this study, rat liver microsomes were used to prepare radiometabolites of the dopamine transporter radioligand [F]FE-PE2I for in vitro imaging using autoradiography and in vivo imaging using PET in rats and nonhuman primates. The primary investigated hydroxy-metabolite [F]FE-PE2I-OH ([F]) was obtained in a 2% radiochemical yield and >99% radiochemical purity. In vitro and in vivo imaging demonstrated that [F] readily crossed the blood-brain barrier and bound specifically and reversibly to the dopamine transporter. In conclusions, the current study demonstrates the potential of liver microsomes in the production of radiometabolites for translational imaging studies and radioligand discovery.

摘要

未代谢的放射性代谢物可能会对正电子发射断层扫描(PET)放射性配体的发展产生不利影响。定量检测脑组织中放射性配体代谢物的方法包括小动物的离体研究或感兴趣的放射性代谢物的标记和成像。后者是一个耗时且资源密集型的过程,通常包括多步有机合成。我们假设可以利用肝脏微粒体(一种模拟代谢的体外系统)来替代这个过程。在这项研究中,使用大鼠肝脏微粒体来制备多巴胺转运体放射性配体[F]FE-PE2I 的放射性代谢物,用于使用放射自显影进行体外成像和使用 PET 在大鼠和非人类灵长类动物进行体内成像。主要研究的羟基代谢物[F]FE-PE2I-OH([F])的放射性化学产率为 2%,放射性化学纯度>99%。体外和体内成像研究表明,[F]很容易穿过血脑屏障,并特异性和可逆地与多巴胺转运体结合。总之,目前的研究表明肝脏微粒体在生产放射性代谢物用于转化成像研究和放射性配体发现方面具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/f218fabbc1e1/cn3c00458_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/e29a2974c77e/cn3c00458_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/9c652503ff76/cn3c00458_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/82b0d4e54729/cn3c00458_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/d2cd79f1330e/cn3c00458_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/1c980d629122/cn3c00458_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/f218fabbc1e1/cn3c00458_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/e29a2974c77e/cn3c00458_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/9c652503ff76/cn3c00458_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/82b0d4e54729/cn3c00458_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/d2cd79f1330e/cn3c00458_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/1c980d629122/cn3c00458_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ead1/10587862/f218fabbc1e1/cn3c00458_0006.jpg

相似文献

1
Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [F]FE-PE2I-OH for Translational Dopamine Transporter Imaging.微粒体介导的体外代谢:用于制备用于转化多巴胺转运蛋白成像的 PET 放射性配体代谢物 [F]FE-PE2I-OH 的便捷方法。
ACS Chem Neurosci. 2023 Oct 18;14(20):3732-3736. doi: 10.1021/acschemneuro.3c00458. Epub 2023 Sep 27.
2
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.新型多巴胺转运体PET放射性配体[18F]FE-PE2I的体外放射自显影及食蟹猴体内评估
Synapse. 2009 Oct;63(10):871-80. doi: 10.1002/syn.20670.
3
Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.使用 18F-FE-PE2I PET 对人脑多巴胺转运体进行定量研究。
J Nucl Med. 2012 Jul;53(7):1065-73. doi: 10.2967/jnumed.111.101626. Epub 2012 Jun 11.
4
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.新型多巴胺转运体探针[18F]FE-PE2I的合成、放射性标记及初步体内评估
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4843-5. doi: 10.1016/j.bmcl.2009.06.032. Epub 2009 Jun 13.
5
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.人脑区域[11C]PE2I与多巴胺转运体结合的定量分析:一项正电子发射断层扫描(PET)研究。
Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):657-68. doi: 10.1007/s00259-005-0027-9. Epub 2006 Mar 3.
6
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.帕金森病中¹⁸F -(E)-N -(3 - 碘丙 - 2 - 烯基)- 2β - 碳氟乙氧基 - 3β -(4'-甲基 - 苯基)去甲托烷与多巴胺转运体结合的定量分析
J Nucl Med. 2015 May;56(5):714-20. doi: 10.2967/jnumed.114.152421. Epub 2015 Mar 19.
7
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.多巴胺转运体PET放射性配体[11C]PE2I在大鼠脑中放射性代谢物的鉴定及区域分布
Eur J Nucl Med Mol Imaging. 2007 May;34(5):667-678. doi: 10.1007/s00259-006-0277-1. Epub 2006 Nov 10.
8
PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.用[(18)F]FE-PE2I对多巴胺转运体进行正电子发射断层显像:抗帕金森病药物的影响。
Nucl Med Biol. 2016 Feb;43(2):158-64. doi: 10.1016/j.nucmedbio.2015.11.002. Epub 2015 Nov 5.
9
Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.在健康对照者和帕金森病患者中使用18F-FE-PE2I的多巴胺转运体可用性的最佳采集时间窗及简化定量分析
J Nucl Med. 2016 Oct;57(10):1529-1534. doi: 10.2967/jnumed.115.171231. Epub 2016 May 26.
10
Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.使用 11C-PE2I 和 18F-FE-PE2I 对非人类灵长类动物大脑中的多巴胺转运体进行动力学分析和定量。
J Nucl Med. 2011 Jan;52(1):132-9. doi: 10.2967/jnumed.110.077651.

本文引用的文献

1
Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.帕金森病中¹⁸F -(E)-N -(3 - 碘丙 - 2 - 烯基)- 2β - 碳氟乙氧基 - 3β -(4'-甲基 - 苯基)去甲托烷与多巴胺转运体结合的定量分析
J Nucl Med. 2015 May;56(5):714-20. doi: 10.2967/jnumed.114.152421. Epub 2015 Mar 19.
2
Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.通过细胞色素 P450、UHPLC/Q-ToF-MS 和快速无线电-LC 鉴定 PET 放射性代谢产物:应用于 PET 放射性配体 [11C]氟马西尼、[18F]FE-PE2I 和 [11C]PBR28。
Anal Bioanal Chem. 2013 Feb;405(4):1303-10. doi: 10.1007/s00216-012-6541-2. Epub 2012 Nov 21.
3
Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.使用 18F-FE-PE2I PET 对人脑多巴胺转运体进行定量研究。
J Nucl Med. 2012 Jul;53(7):1065-73. doi: 10.2967/jnumed.111.101626. Epub 2012 Jun 11.
4
Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.使用 11C-PE2I 和 18F-FE-PE2I 对非人类灵长类动物大脑中的多巴胺转运体进行动力学分析和定量。
J Nucl Med. 2011 Jan;52(1):132-9. doi: 10.2967/jnumed.110.077651.
5
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.新型多巴胺转运体探针[18F]FE-PE2I的合成、放射性标记及初步体内评估
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4843-5. doi: 10.1016/j.bmcl.2009.06.032. Epub 2009 Jun 13.
6
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.新型多巴胺转运体PET放射性配体[18F]FE-PE2I的体外放射自显影及食蟹猴体内评估
Synapse. 2009 Oct;63(10):871-80. doi: 10.1002/syn.20670.
7
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.使用HRRT通过3D-OP-OSEM点扩散函数重建进行PET定量分析的进展。
Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1639-50. doi: 10.1007/s00259-009-1156-3. Epub 2009 May 13.
8
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.多巴胺转运体PET放射性配体[11C]PE2I在大鼠脑中放射性代谢物的鉴定及区域分布
Eur J Nucl Med Mol Imaging. 2007 May;34(5):667-678. doi: 10.1007/s00259-006-0277-1. Epub 2006 Nov 10.
9
Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I.利用新型选择性配体[125I]PE2I对人死后大脑中的多巴胺转运体进行可视化研究。
Neuroimage. 1999 Jan;9(1):108-16. doi: 10.1006/nimg.1998.0366.
10
Whole hemisphere autoradiography of the postmortem human brain.死后人类大脑的全脑半球放射自显影术。
Nucl Med Biol. 1998 Nov;25(8):715-9. doi: 10.1016/s0969-8051(98)00053-5.